×
S&P 500   4,143.97 (+2.12%)
DOW   33,089.77 (+1.39%)
QQQ   307.62 (+2.77%)
AAPL   148.77 (+3.47%)
MSFT   270.98 (+1.91%)
FB   194.22 (+1.35%)
GOOGL   2,239.99 (+3.90%)
AMZN   2,282.10 (+2.73%)
TSLA   755.27 (+6.72%)
NVDA   187.55 (+5.06%)
BABA   93.29 (-1.26%)
NIO   16.50 (+2.93%)
AMD   101.90 (+3.19%)
CGC   4.88 (-12.07%)
MU   73.13 (+3.58%)
T   21.21 (-0.52%)
GE   78.24 (+1.60%)
F   13.58 (+3.51%)
DIS   108.96 (+3.17%)
AMC   14.24 (+16.43%)
PFE   53.60 (-0.72%)
PYPL   84.79 (+5.43%)
NFLX   193.81 (+1.26%)
S&P 500   4,143.97 (+2.12%)
DOW   33,089.77 (+1.39%)
QQQ   307.62 (+2.77%)
AAPL   148.77 (+3.47%)
MSFT   270.98 (+1.91%)
FB   194.22 (+1.35%)
GOOGL   2,239.99 (+3.90%)
AMZN   2,282.10 (+2.73%)
TSLA   755.27 (+6.72%)
NVDA   187.55 (+5.06%)
BABA   93.29 (-1.26%)
NIO   16.50 (+2.93%)
AMD   101.90 (+3.19%)
CGC   4.88 (-12.07%)
MU   73.13 (+3.58%)
T   21.21 (-0.52%)
GE   78.24 (+1.60%)
F   13.58 (+3.51%)
DIS   108.96 (+3.17%)
AMC   14.24 (+16.43%)
PFE   53.60 (-0.72%)
PYPL   84.79 (+5.43%)
NFLX   193.81 (+1.26%)
S&P 500   4,143.97 (+2.12%)
DOW   33,089.77 (+1.39%)
QQQ   307.62 (+2.77%)
AAPL   148.77 (+3.47%)
MSFT   270.98 (+1.91%)
FB   194.22 (+1.35%)
GOOGL   2,239.99 (+3.90%)
AMZN   2,282.10 (+2.73%)
TSLA   755.27 (+6.72%)
NVDA   187.55 (+5.06%)
BABA   93.29 (-1.26%)
NIO   16.50 (+2.93%)
AMD   101.90 (+3.19%)
CGC   4.88 (-12.07%)
MU   73.13 (+3.58%)
T   21.21 (-0.52%)
GE   78.24 (+1.60%)
F   13.58 (+3.51%)
DIS   108.96 (+3.17%)
AMC   14.24 (+16.43%)
PFE   53.60 (-0.72%)
PYPL   84.79 (+5.43%)
NFLX   193.81 (+1.26%)
S&P 500   4,143.97 (+2.12%)
DOW   33,089.77 (+1.39%)
QQQ   307.62 (+2.77%)
AAPL   148.77 (+3.47%)
MSFT   270.98 (+1.91%)
FB   194.22 (+1.35%)
GOOGL   2,239.99 (+3.90%)
AMZN   2,282.10 (+2.73%)
TSLA   755.27 (+6.72%)
NVDA   187.55 (+5.06%)
BABA   93.29 (-1.26%)
NIO   16.50 (+2.93%)
AMD   101.90 (+3.19%)
CGC   4.88 (-12.07%)
MU   73.13 (+3.58%)
T   21.21 (-0.52%)
GE   78.24 (+1.60%)
F   13.58 (+3.51%)
DIS   108.96 (+3.17%)
AMC   14.24 (+16.43%)
PFE   53.60 (-0.72%)
PYPL   84.79 (+5.43%)
NFLX   193.81 (+1.26%)
LON:PYC

Physiomics (PYC) Share Forecast, Price & News

GBX 4.08
+0.03 (+0.74%)
(As of 05/27/2022 04:12 PM ET)
Add
Compare
Today's Range
4
4.08
50-Day Range
4.02
5.09
52-Week Range
3.84
7.94
Volume
79,190 shs
Average Volume
454,087 shs
Market Capitalization
£3.97 million
P/E Ratio
N/A
Dividend Yield
N/A
Beta
N/A
30 days | 90 days | 365 days | Advanced Chart
Receive PYC News and Ratings via Email

Sign-up to receive the latest news and ratings for Physiomics and its competitors with MarketBeat's FREE daily newsletter.

About Physiomics

Physiomics Plc provides consulting services to pharmaceutical companies in the areas of outsourced quantitative pharmacology and computational biology in the United Kingdom, the United States, and the European Union. It offers modeling, simulation, and data analysis services covering various ranges of oncology research and development using its proprietary Virtual Tumour predictive software. The company also develops technology for use in the field of personalized medicine. Physiomics Plc was incorporated in 2001 and is based in Oxford, the United Kingdom.

Headlines

See More Headlines

Industry, Sector and Symbol

Industry
Biotechnology
Sub-Industry
N/A
Sector
Medical
CIK
N/A
Fax
N/A
Employees
7
Year Founded
N/A

Sales & Book Value

Annual Sales
£739.90 thousand
Cash Flow
GBX 0.78 per share
Book Value
GBX 1.10 per share

Profitability

Pretax Margin
N/A

Debt

Price-To-Earnings

Miscellaneous

Free Float
N/A
Market Cap
£3.97 million
Optionable
Not Optionable

Company Calendar

Last Earnings
9/30/2020
Today
5/27/2022

MarketRank

Overall MarketRank

0.75 out of 5 stars

Analyst Opinion: 0.0Community Rank: 3.7Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 0.0 5 -4 -3 -2 -1 -













Physiomics (LON:PYC) Frequently Asked Questions

How were Physiomics' earnings last quarter?

Physiomics Plc (LON:PYC) announced its earnings results on Wednesday, September, 30th. The company reported ($0.09) earnings per share (EPS) for the quarter.
View Physiomics' earnings history
.

Who are Physiomics' key executives?
Physiomics' management team includes the following people:
  • Dr. James Simon Millen, CEO & Exec. Chairman (Age 53, Pay $146.08k)
  • Dr. Christophe D. Chassagnole, COO & Exec. Director
  • Prof. David Fell, Co-Founder & Member of Scientific Advisory Board
  • Mr. Anthony Louis Clayden ACA, BSc (Hons), MSI, Head of Fin. & Company Sec. (Age 54)
  • Ms. Charmaine Fraser, Admin. Mang.
  • Ms. Hayley Close, Head of Bus. Devel.
  • Dr. Mark Middleton M.D., Ph.D., Consultant & Member of Scientific Advisory Board
  • Dr. Robert Jackson Ph.D., Consultant & Member of Scientific Advisory Board (Age 78)
What other stocks do shareholders of Physiomics own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Physiomics investors own include Andalas Energy and Power (ADL), Uranium Energy (UEC), Tavistock Investments (TAVI), Sorrento Therapeutics (SRNE), Photonstar Led Group (PSL), (OCT), IGas Energy (IGAS) and Hertz Global (HTZ).

What is Physiomics' stock symbol?

Physiomics trades on the London Stock Exchange (LON) under the ticker symbol "PYC."

How do I buy shares of Physiomics?

Shares of PYC and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.
Compare Top Brokerages Here.

What is Physiomics' stock price today?

One share of PYC stock can currently be purchased for approximately GBX 4.08.

How much money does Physiomics make?

Physiomics has a market capitalization of £3.97 million and generates £739.90 thousand in revenue each year.

How many employees does Physiomics have?

Physiomics employs 7 workers across the globe.

What is Physiomics' official website?

The official website for Physiomics is www.physiomics-plc.com.

How can I contact Physiomics?

Physiomics' mailing address is Magdalen Centre 1 Robert Robinson Avenue, OXFORD, OX4 4GA, United Kingdom. The company can be reached via phone at +44-1865-784980.

This page was last updated on 5/27/2022 by MarketBeat.com Staff

Resources

Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau MarketBeat is rated as Great on TrustPilot

© American Consumer News, LLC dba MarketBeat® 2010-2022. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information | RSS Feeds

© 2022 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research.